Theatre Alliance of Buffalo Announces APPLAUSE FOR HOPE Fundraiser

By: Feb. 04, 2013
Get Access To Every Broadway Story

Unlock access to every one of the hundreds of articles published daily on BroadwayWorld by logging in with one click.




Existing user? Just click login.

The Theatre Alliance of Buffalo (TAB) announced a collaborative fundraising event called APPLAUSE FOR HOPE in support of Roswell Park Cancer Institute (RPCI). On Saturdays in February 2013, fourteen participating TAB theaters will be donating 30%* of their ticket sales to fund RPCI's extraordinary work on a cancer vaccine and its promise to save lives. For more information visit www.theatreallianceofbuffalo.com.

To participate in APPLAUSE FOR HOPE, theatregoers simply buy single tickets at any of the following theatres:

Road Less Traveled Productions*
Irish Classical Theatre Company
Theatre of Youth Jewish Repertory Theatre
MusicalFare Theatre Paul Robeson Theatre
Subversive Theatre Collective The Kavinoky Theatre
Buffalo Laboratory Theatre
Buffalo United Artists Shea's Performing Arts Center*
O'Connell & Company Productions Torn Space Theater
Lancaster Opera House

TAB president Robert Brunschmid says "APPLAUSE FOR HOPE audiences can enjoy their show even more knowing that they have contributed to the fight against cancer." Brunschmid continues, "There are such a variety of shows playing in February we hope that patrons will consider seeing more than one APPLAUSE FOR HOPE performance-perhaps at a theatre they have yet to attend."

The Theatre Alliance of Buffalo (TAB) is a consortium of Western New York professional theatre companies dedicated to promoting the welfare of its 20 member organizations and appreciation of the art of theatre.

In 2012, Roswell Park Cancer Institute (RPCI) brought worldwide attention to Buffalo when it launched a clinical trial for a cancer vaccine that has the potential to be a game changer in the treatment of cancer. To reach this level of early-stage testing is a significant achievement and the vaccine shows great promise for treating patients with many kinds of cancer tumors. Right now, efforts are underway at RPCI to secure funding for the next phase of the clinical trial, which is expected to begin this year.



Comments

To post a comment, you must register and login.

Vote Sponsor


Videos